Literature DB >> 30761872

Branch retinal vein occlusion associated with platelet activation

Emrullah Beyazyıldız, Mehmet Çıtırık, Mert Şimşek, Özlem Beyazyıldız, İbrahim C Haznedaroğlu.   

Abstract

Background/aim: The aim of this study is to study subclinical platelet activation by detecting three important platelet activation parameters of mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit (PCT) in patients with branch retinal vein occlusion (BRVO) in comparison to those in healthy control subjects. Materials and methods: This prospective study included 43 patients with BRVO (Group 1)and 40 control subjects (Group 2). The levels of MPV, PDW, and PCT were measured in both of the studied groups
Results: The mean serum level of MPV value was 7.64 ± 0.64 in Group 1 and 7.39 ± 0.42 in Group 2. Mean serum level of PDW was 15.01 ± 1.56 in Group 1 and 14.43 ± 1.03 in Group 2. Mean serum PCT value was 0.19 ± 0.05 in Group 1 and 0.16 ± 0.04 in Group 2. MPV, PDW, and PCT levels were significantly increased in BRVO patients (P < 0.05).
Conclusion: Subclinical platelet activation reflected by MPV, PDW, and PCT may have an impact on the genesis of vessel occlusion in BRVO. The results may be important for the clinical management of patients with BRVO

Entities:  

Keywords:  Branch retinal vein occlusion; mean platelet volume; plateletcrit; platelet distribution width; platelet parameters; retina,

Mesh:

Year:  2019        PMID: 30761872     DOI: 10.3906/sag-1807-223

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  5 in total

1.  Assessment of platelet-to-lymphocyte ratio in patients with retinal vein occlusion.

Authors:  Bengi Ece Kurtul; Ayșe İdil Çakmak; Ahmet Elbeyli; Deniz Özarslan Özcan; Sait Coșkun Özcan; Veysel Cankurtaran
Journal:  Ther Adv Ophthalmol       Date:  2020-11-18

2.  Systemic antiplatelet agents and anticoagulants in eyes with branch retinal vein occlusion.

Authors:  Pali P Singh; Durga S Borkar; Cason B Robbins; Jane S Kim; Faith Birnbaum; Maria Gomez-Caraballo; Akshay S Thomas; Sharon Fekrat
Journal:  Ther Adv Ophthalmol       Date:  2021-09-02

3.  Complete Blood Count-Derived Inflammation Indices and Retinal Vein Occlusion: A Case-Control Study.

Authors:  Dimitrios Kazantzis; Genovefa Machairoudia; Christos Kroupis; George Theodossiadis; Panagiotis Theodossiadis; Irini Chatziralli
Journal:  Ophthalmol Ther       Date:  2022-05-03

4.  Platelet-Derived Procoagulant Microvesicles Are Elevated in Patients with Retinal Vein Occlusion (RVO).

Authors:  Adrianna Marcinkowska; Nina Wolska; Boguslawa Luzak; Slawomir Cisiecki; Karol Marcinkowski; Marcin Rozalski
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

5.  Central retinal vein occlusion associated with platelet activation.

Authors:  Mehmet Citirik
Journal:  Ther Adv Ophthalmol       Date:  2019-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.